The Risks of Teen Vaping: Understanding E-Cigarette Addiction

Sep.05.2022
The Risks of Teen Vaping: Understanding E-Cigarette Addiction
Electronic cigarettes are popular with teens, but can be addictive and pose health risks. CDC data shows rising use.

According to data from the CDC, electronic cigarettes have been the most commonly used tobacco products among youth since 2014. Many young people believe that using e-cigarettes or vaping is not a big deal, and as a result, the number of youth using electronic cigarettes is increasing.


The working principle of e-cigarettes involves heating a liquid until it turns into vapor, and then inhaling it. The inhaled liquid may contain oil, marijuana, or the most common ingredient, nicotine. According to a 2021 report from the CDC, one in every 35 middle school students and one in every nine high school students have used e-cigarettes in the past 30 days.


According to Child Mind Institute, addiction is easy for teenagers because their brains are still developing, making them more vulnerable to addiction. Nicotine found in electronic cigarettes can cause harm to their developing brains.


Many e-cigarette users believe that using these products is a safer alternative to traditional tobacco use and will aid in smoking cessation efforts. However, e-cigarettes and their accompanying products can lead to addiction, with some studies suggesting that they are more difficult to quit than traditional cigarettes. This is due to the increased levels of nicotine found in e-cigarettes.


There are many factors that can lead teenagers to decide to use electronic cigarettes: they may see family members or friends using them, and companies tend to design packaging to enhance the appeal of different flavors and varieties of e-cigarettes to teenagers. Additionally, e-cigarette products are cheaper and more readily available than traditional tobacco products.


Using e-cigarettes poses some health risks, including addiction, anxiety and depression, acid reflux, sleep problems, increased thirst due to mouth and throat dehydration, chronic coughing, nosebleeds, exposure to carcinogenic chemicals, chronic bronchitis, and potentially life-threatening lung injuries.


Statement: 1. This article is compiled from third-party information for the purpose of industry exchange and learning. 2. The views expressed in this article do not represent those of 2FIRSTS, and 2FIRSTS cannot confirm the authenticity or accuracy of the article's content. The compilation of this article is intended for industry exchange and research only. 3. Due to limited compilation ability, the compiled article may not express the original text exactly the same, please refer to the original text. 4. Regarding any domestic, Hong Kong, Macao, Taiwan, and foreign statements and positions, 2FIRSTS is completely aligned with the Chinese government. 5. The copyright of the compiled information belongs to the original media and author. If there is any infringement, please contact us to delete it.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Imperial Brands Pulls myblu Vape Business From U.S., Citing Prolonged FDA Approval Process
Imperial Brands Pulls myblu Vape Business From U.S., Citing Prolonged FDA Approval Process
Imperial Brands said it will phase out its myblu vaping business in the United States, citing prolonged FDA approval timelines for new vape products. The company said it will instead focus on modern oral nicotine products in the U.S., including the expansion of its Zone brand and new flavors. While overall next-generation product revenue continued to grow, revenue from the category in the Americas declined sharply.
May.12
JTI Korea Introduces Ploom AURA With Four Heating Modes and Four Device Colors
JTI Korea Introduces Ploom AURA With Four Heating Modes and Four Device Colors
JTI Korea announced that its next-generation heated tobacco device Ploom AURA will officially launch in South Korea on April 14. The company held a media event on March 31 at the Fairmont Ambassador Seoul Hotel to unveil the product in Korea for the first time.
Apr.01 by 2FIRSTS.ai
FDA Commissioner Marty Makary Resigns After Opposing Trump Administration’s Flavored Vape Push
FDA Commissioner Marty Makary Resigns After Opposing Trump Administration’s Flavored Vape Push
FDA Commissioner Marty Makary resigned on May 12 after opposing the Trump administration’s push to authorize fruit-flavored vaping products, according to reporting by The New York Times. Makary reportedly objected over concerns that flavored vapes could attract young people and refused to support broader approvals.
News
May.13
JTI Invests EUR 300 Million in New Factory in Romania to Advance Its Localized Expansion
JTI Invests EUR 300 Million in New Factory in Romania to Advance Its Localized Expansion
After being present in Romania for more than 30 years, Japan Tobacco International (JTI) announced that it will invest approximately EUR 300 million (about USD 324 million) to build a green, state-of-the-art new factory in Ilfov County, Romania, reinforcing its long-term commitment to the country.
Mar.31 by 2FIRSTS.ai
Russia May Allow Regions to Introduce Experimental Vape Sales Bans
Russia May Allow Regions to Introduce Experimental Vape Sales Bans
Russia’s government commission on legislative activity has approved second-reading amendments to a bill on licensing trade in tobacco and nicotine-containing products that would allow Russian regions to introduce experimental bans on vape sales.
Mar.31 by 2FIRSTS.ai
Acting CTP Director Says FDA Cut Premarket Tobacco Application Backlog by About 70% Over the Past Year
Acting CTP Director Says FDA Cut Premarket Tobacco Application Backlog by About 70% Over the Past Year
FDA Center for Tobacco Products Acting Director Bret Koplow said at the American Tobacco and Nicotine Forum that the agency has reduced its premarket tobacco application backlog by about 70% over the past year and eliminated the acceptance queue. He said FDA has reviewed about 27 million applications, but only a small number have been authorized, mainly because most submissions lacked the scientific data needed to demonstrate public health benefits.
Apr.23 by 2FIRSTS.ai